CymaBay Therapeutics Inc (NASDAQ:CBAY)

9.17
Delayed Data
As of Jun 09
 -0.14 / -1.50%
Today’s Change
1.81
Today|||52-Week Range
11.22
+46.25%
Year-to-Date

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for CymaBay Therapeutics Inc have a median target of 15.00, with a high estimate of 19.00 and a low estimate of 8.00. The median estimate represents a +63.58% increase from the last price of 9.17.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in CymaBay Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.19
Sales
$12.8M
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 34.54%
 
 
 
 
 
 
Growthannually 15.35%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.